 SOUTH SAN FRANCISCO, Calif., May 05, 2021 GLOBE NEWSWIRE -- Alector, Inc. Nasdaq: ALEC, a clinical-stage biotechnology company pioneering immuno-neurology, today announced business updates and financial results for the first quarter ended March 31, 2021. 